Profil bibliographique

Erin E. Stebbins

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées

581Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Parasitic Infections and DiagnosticsPneumocystis jirovecii pneumonia detection and treatmentOrthopedic Infections and TreatmentsCoccidia and coccidiosis researchAntibiotic Resistance in Bacteria

Publications récentes

Accès ouvert 2024 articleOpenAlex

Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male mice

Jubilee Ajiboye, José E. Teixeira, Makafui Gasonoo, Ethan B. Mattice et autres

14 citationsNature Communications

Accès ouvert 2024 articleOpenAlex

Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiation

Muhammad M. Hasan, Ethan B. Mattice, José E. Teixeira, Rajiv S. Jumani et autres

7 citationsPLoS Pathogens

Accès ouvert 2023 preprintOpenAlex

Cryptosporidium Life Cycle Small Molecule Probing Implicates Translational Repression And An Apetala 2 Transcription Factor In Sexual Differentiation

Muhammad Mahmudul Hasan, Ethan B. Mattice, José E. Teixeira, Rajiv S. Jumani et autres

1 citationbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2023 preprintOpenAlex

Identification of potent and orally efficacious phosphodiesterase inhibitors in s Cryptosporidium parvum- infected immunocompromised mice

José E. Teixeira, Makafui Gasonoo, Peter G. Miller, Jubilee Ajiboye et autres

0 citationsbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2023 articleOpenAlex

Structure–Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Cryptosporidium Reveals Remarkable Role of Fluorine

Tanner J. Schubert, Edmund Oboh, H. W. Peek, Emily Philo et autres

9 citationsJournal of Medicinal Chemistry

Accès ouvert 2021 articleOpenAlex

Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin

Edmund Oboh, Tanner J. Schubert, José E. Teixeira, Erin E. Stebbins et autres

21 citationsJournal of Medicinal Chemistry

Accès ouvert 2021 articleOpenAlex

Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection

Muhammad M. Hasan, Erin E. Stebbins, Robert K. M. Choy, J. Robert Gillespie et autres

32 citationsAntimicrobial Agents and Chemotherapy

Accès ouvert 2021 preprintOpenAlex

Spontaneous selection of Cryptosporidium drug resistance in a calf model of infection

Muhammad M. Hasan, Erin E. Stebbins, Robert K. M. Choy, J. Robert Gillespie et autres

1 citationbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2020 articleOpenAlex

Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase

Sumiti Vinayak, Rajiv S. Jumani, Peter G. Miller, Muhammad M. Hasan et autres

83 citationsScience Translational Medicine

Accès ouvert 2020 articleOpenAlex

Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity

Gretchen Ehrenkaufer, Pengyang Li, Erin E. Stebbins, Mônica Mendes Kangussu-Marcolino et autres

29 citationsPLoS neglected tropical diseases

Accès ouvert 2019 articleOpenAlex

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani, Mahmudul Hasan et autres

66 citationsNature Communications

Accès ouvert 2019 articleOpenAlex

A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors

Rajiv S. Jumani, Muhammad M. Hasan, Erin E. Stebbins, Liam Donnelly et autres

53 citationsNature Communications

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.